Table 1. Characteristics of this study.
All values are pre-imputation values. Continuous variables are reported as median (interquartile range). Categorical variables are reported as percentages, with proportions in parentheses. NLR: neutrophil-lymphocyte ratio, PLR: platelet-lymphocyte ratio.
| Viral AG (N = 52) | Bacterial AG (N = 112) | p-value | |
| Continuous variables | |||
| Age (months) | 29.0 (12.8-51.0) | 19.0 (8.0-30.3) | <0.05 |
| Height (m) | 0.87 (0.73-1.04) | 0.80 (0.70-0.92) | 0.12 |
| Weight (kg) | 12.5 (9.5-17.1) | 10.5 (7.5-13.0) | <0.05 |
| WBC (106/L) | 8500 (6775-11825) | 11975 (8900-15008) | <0.05 |
| Neutrophils (106/L) | 5550 (3150-8525) | 5750 (3270-8988) | 0.48 |
| Lymphocyte (106/L) | 2000 (1000-3475) | 3395 (1978-5855) | <0.05 |
| Monocyte (106/L) | 800 (675-1000) | 1035 (595-1425) | <0.05 |
| Eosinophils (106/L) | 0.0 (0-0) | 60.0 (0-200) | <0.05 |
| Basophil (106/L) | 0.0 (0-100) | 35.0 (0-105) | <0.05 |
| RBC (106/µL) | 4.23 (3.92-4.50) | 4.14 (3.77-4.47) | 0.16 |
| Platelet (cells/µL) | 282500 (243750-349250) | 322000 (240250-385000) | 0.54 |
| Highest temperature (℃) | 38.0 (37.0-38.5) | 38.0 (36.9-39.0) | 0.91 |
| NLR | 2.47 (1.04-8.41) | 1.48 (0.75-3.48) | <0.05 |
| PLR | 159.51 (79.75-290.09) | 87.48 (56.66-30.32) | <0.05 |
| Categorical variables | |||
| WHO_score | 0.12 | ||
| Mild | 33 (63%) | 62 (55%) | |
| Moderate | 8 (15%) | 10 (9%) | |
| Severe | 11 (21%) | 40 (36%) | |
| Sex | 0.61 | ||
| Female | 18 (35%) | 45 (40%) | |
| Male | 34 (65%) | 67 (60%) | |
| Duration (days) | 0.74 | ||
| 0-5 | 21 (40%) | 50 (45%) | |
| 6-10 | 27 (52%) | 50 (45%) | |
| 11- | 4 (8%) | 10 (9%) | |
| Onset (days) | 0.64 | ||
| 1-3 | 37 (71%) | 74 (66%) | |
| 4- | 15 (29%) | 38 (34%) | |
| Vaccine (times) | 0.14 | ||
| 0 | 27 (52%) | 43 (38%) | |
| 1-3 | 25 (48%) | 69 (62%) |